Patent details

EP3217983 Title: ENHANCEMENT OF TUMOR RESPONSE TO CHEMOTHERAPY BY ACTIVATION OF THE ASMASE/CERAMIDE PATHWAY THROUGH TIMED ADMINISTRATION OF A SHORT-ACTING ANTI-ANGIOGENIC AGENT

Basic Information

Publication number:
EP3217983
PCT Application Number:
US2015060486
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP158594622
PCT Publication Number:
WO2016077652
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ENHANCEMENT OF TUMOR RESPONSE TO CHEMOTHERAPY BY ACTIVATION OF THE ASMASE/CERAMIDE PATHWAY THROUGH TIMED ADMINISTRATION OF A SHORT-ACTING ANTI-ANGIOGENIC AGENT
French Title of Invention:
AMÉLIORATION DE LA RÉPONSE TUMORALE À UNE CHIMIOTHÉRAPIE PAR ACTIVATION DE LA VOIE ASMASE/CÉRAMIDE À L'AIDE D'UNE ADMINISTRATION À LIBÉRATION PROLONGÉE D'UN AGENT ANTI-ANGIOGÉNIQUE
German Title of Invention:
ERHÖHUNG DER TUMORREAKTION AUF EINE CHEMOTHERAPIE DURCH AKTIVIERUNG DES ASMASE-/CERAMIDPFADS DURCH ZEITGESTEUERTE VERABREICHUNG EINES KURZFRISTIG WIRKENDEN ANTI-ANGIOGENITISCHEN WIRKSTOFFES
SPC Number:

Dates

Filing date:
12/11/2015
Grant date:
01/05/2024
EP Publication Date:
20/09/2017
PCT Publication Date:
19/05/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/05/2024
EP B1 Publication Date:
01/05/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/11/2024
Expiration date:
12/11/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/04/2024
 
 

Name:
Memorial Sloan Kettering Cancer Center
Address:
1275 York Avenue, New York, NY 10021, United States (US)

Inventor

1

Name:
HAIMOVITZ-FRIEDMAN, Adriana
Address:
United States (US)

2

Name:
SALA, Evis
Address:
United States (US)

3

Name:
KOLESNICK, Richard
Address:
United States (US)

4

Name:
FUKS, Zvi
Address:
United States (US)

Priority

Priority Number:
201462078280 P
Priority Date:
11/11/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/517; A61K 31/416; A61K 31/404; A61K 31/136; A61K 31/66; A61K 31/198; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202418
Publication date:
01/05/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages